Pharmacopeia, Inc.
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
5
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 18, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,723,340 | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith In force · From the USPTO record | In force | From the USPTO record | |
| US 7,759,353 | Substituted Spiro Iminopyrimidinones as Aspartyl Protease Inhibitors, Compositions, and Methods of Treatment In force · High confidence | In force | High confidence | |
| US 8,148,391 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 7,989,459 | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 8,288,371 | Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 5: 8 patents in force now held by others · 91 lapsed for an unpaid fee · 62 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 7 no status recorded